These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35091264)

  • 21. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study.
    El Khoudary ( سمر رياض الخضري ) SR; Chen (陈曦润) X; Nasr ( ألكسس نصر ) AN; Billheimer J; Brooks MM; McConnell D; Orchard TJ; Crawford SL; Matthews KA; Rader DJ
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):951-961. PubMed ID: 33267661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomic Profiling of Cholesterol Efflux Capacity in a Multiethnic Population: Insights From MESA.
    Hunter WG; Smith AG; Pinto RC; Saldanha S; Gangwar A; Pahlavani M; Deodhar S; Wilkins J; Pandey A; Herrington D; Greenland P; Tzoulaki I; Rohatgi A
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2030-2041. PubMed ID: 37615111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation, remodeling, and other factors affecting HDL cholesterol efflux.
    Ronsein GE; Vaisar T
    Curr Opin Lipidol; 2017 Feb; 28(1):52-59. PubMed ID: 27906712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis.
    Srivastava N; Cefalu AB; Averna M; Srivastava RAK
    Front Physiol; 2018; 9():1222. PubMed ID: 30271349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis.
    Ganda A; Magnusson M; Yvan-Charvet L; Hedblad B; Engström G; Ai D; Wang TJ; Gerszten RE; Melander O; Tall AR
    Circulation; 2013 Mar; 127(9):988-96. PubMed ID: 23378299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men.
    Cahill LE; Sacks FM; Rimm EB; Jensen MK
    J Lipid Res; 2019 Aug; 60(8):1457-1464. PubMed ID: 31142574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction.
    Oniki K; Ogura M; Matsumoto E; Watanabe H; Imafuku T; Seguchi Y; Arima Y; Fujisue K; Yamanaga K; Yamamoto E; Maeda H; Ogata Y; Yoshida M; Harada-Shiba M; Maruyama T; Tsujita K; Saruwatari J
    J Atheroscler Thromb; 2024 Aug; 31(8):1149-1161. PubMed ID: 38382967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients.
    Shao B; Afshinnia F; Mathew AV; Ronsein GE; Thornock C; Irwin AD; Kansal M; Rao PS; Dobre M; Al-Kindi S; Weir MR; Go A; He J; Chen J; Feldman H; Bornfeldt KE; Pennathur S;
    J Lipid Res; 2023 Jun; 64(6):100381. PubMed ID: 37100172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL Cholesterol Efflux Capacity is Impaired in Severe Short-Term Hypothyroidism Despite Increased HDL Cholesterol.
    van der Boom T; Jia C; Lefrandt JD; Connelly MA; Links TP; Tietge UJF; Dullaart RPF
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3355-62. PubMed ID: 32761088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes.
    Costacou T; Vaisar T; Miller RG; Davidson WS; Heinecke JW; Orchard TJ; Bornfeldt KE
    medRxiv; 2023 Nov; ():. PubMed ID: 37986833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis.
    Fadaei R; Poustchi H; Meshkani R; Moradi N; Golmohammadi T; Merat S
    Sci Rep; 2018 Aug; 8(1):11691. PubMed ID: 30076407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.
    Yokoyama K; Tani S; Matsuo R; Matsumoto N
    Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.
    Hafiane A; Favari E; Daskalopoulou SS; Vuilleumier N; Frias MA
    Metabolism; 2020 Mar; 104():154141. PubMed ID: 31923386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
    He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
    Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.
    Adorni MP; Ronda N; Bernini F; Zimetti F
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis.
    Tejera-Segura B; Macía-Díaz M; Machado JD; de Vera-González A; García-Dopico JA; Olmos JM; Hernández JL; Díaz-González F; González-Gay MA; Ferraz-Amaro I
    Arthritis Res Ther; 2017 May; 19(1):113. PubMed ID: 28569219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis.
    Sánchez-Pérez H; Quevedo-Abeledo JC; de Armas-Rillo L; Rua-Figueroa Í; Tejera-Segura B; Armas-González E; Machado JD; García-Dopico JA; Jimenez-Sosa A; Rodríguez-Lozano C; Díaz-González F; González-Gay MA; Ferraz-Amaro I
    Rheumatology (Oxford); 2020 Oct; 59(10):2847-2856. PubMed ID: 32065639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study.
    Schachtl-Riess JF; Schönherr S; Lamina C; Forer L; Coassin S; Streiter G; Kheirkhah A; Li Y; Meiselbach H; Di Maio S; Eckardt KU; Köttgen A; Kronenberg F;
    Atherosclerosis; 2023 Mar; 368():1-11. PubMed ID: 36812656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis.
    Favari E; Thomas MJ; Sorci-Thomas MG
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):325-331. PubMed ID: 29528874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.